NDC 0409-2011-05 - LEVETIRACETAM
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-2011
- Requested NDC
- 0409-2011-05
- Package NDCs from labels
- 0409-2011-05, 0409-2011-25
- Manufacturer
- Hospira, Inc.
- Effective date
- 2024-06-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LEVETIRACETAM - Hospira, Inc. | Hospira, Inc. | 2024-06-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-2011-05 | LEVETIRACETAM | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 5 | 6 | |
| 0409-2011-25 | LEVETIRACETAM | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-2011-05 | ML - Milliliter | 0409-2011 | cfbf77d7-cb68-4b0a-83ec-d51f6439312c | 1 | 2021-12-08 |
| 0409-2011-25 | ML - Milliliter | 0409-2011 | 40d66e29-fd6f-4ccc-9595-9ce343868942 | 1 | 2021-12-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Schuessler Tissue Salts Nat Mur Fluid Balance 9 | NATRUM MURIATICUM | Martin & Pleasance Pty Ltd | 0b21c366-fff6-4754-a671-35481ec2c4bd | 2025-07-07 | Warnings | 451W47IQ8X |
| Hydrocortisone and Acetic Acid | HYDROCORTISONE AND ACETIC ACID | Sun Pharmaceutical Industries, Inc. | 6383c722-84e2-4719-a13d-19c54e3eefff | 2025-07-07 | Warnings, Adverse reactions | Q40Q9N063P |
| Normal Salt | SODIUM CHLORIDE | Twin Med LLC | dc82ff0f-8600-373a-e053-2995a90a7505 | 2025-07-03 | Warnings | 451W47IQ8X |
| Sodium Chloride Normal Salt | SODIUM CHLORIDE | Advanced Rx LLC | 40f471b7-27cf-4ad4-aef6-cc9d0623ddd9 | 2025-07-02 | Warnings | 451W47IQ8X |
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | 0956bd7c-d46f-483a-bf2c-9e11c6111ebf | 2025-07-02 | 451W47IQ8X | |
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | b79ef556-37b3-4fd0-8589-c633033be9df | 2025-07-02 | 451W47IQ8X | |
| Levetiracetam | LEVETIRACETAM | Prasco Laboratories | dd175fa3-1d7a-4542-affd-988ac5bba1db | 2025-07-01 | Warnings, Adverse reactions | 44YRR34555 |
| Parasode | ARTEMISIA VULGARIS ROOT, CHELIDONIUM MAJUS WHOLE, PUNICA GRANATUM ROOT BARK, SPIGELIA ANTHELMIA WHOLE, KRAMERIA LAPPACEA ROOT, ARSENIC TRIOXIDE, IRON, OYSTER SHELL CALCIUM CARBONATE, CRUDE, ARTEMISIA CINA PRE-FLOWERING TOP, SALMONELLA ENTERICA ENTERICA SEROVAR ENTERITIDIS, GRAPHITE, CALOMEL, SODIUM CHLORIDE, AND SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | Zorex | 0ed722dc-cd25-4a15-b3f8-052cc7bcd9ec | 2025-07-01 | Warnings | 451W47IQ8X |
| Keppra | LEVETIRACETAM | UCB, Inc. | c6d5784d-abf9-45fe-ac5a-d5c53bd50f7e | 2025-06-30 | Warnings, Adverse reactions | 647121 44YRR34555 |
| EXTRANEAL | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Vantive US Healthcare LLC | d5b85158-b0d6-4855-9d07-8d1b3ad9ab71 | 2025-06-30 | Warnings, Adverse reactions | 451W47IQ8X |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Baxter Healthcare Corporation | 958d35f0-6834-43be-a700-fa58f38b4c19 | 2025-06-30 | Warnings, Adverse reactions | 451W47IQ8X |
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | 17dec820-1b57-4ac9-82a8-419cab664a2f | 2025-06-27 | Warnings, Adverse reactions | 451W47IQ8X 4550K0SC9B |
| Keppra XR | LEVETIRACETAM | UCB, Inc. | 2919e43b-69a8-434c-a2d2-1f3ecd7554c0 | 2025-06-24 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM IN SODIUM CHLORIDE | Caplin Steriles Limited | 563171fb-df26-4f95-853a-fd7707da291c | 2025-06-24 | Warnings, Adverse reactions | 44YRR34555 |
| Plaque identifying | PLAQUE IDENTIFYING | Shenzhen Yagao Technology Co., Ltd. | 37eeb656-22f1-7372-e063-6394a90ad041 | 2025-06-19 | Warnings | 059QF0KO0R |
| HAIR STIM | PEDICULUS CAPITIS, THYROIDINUM (SUIS), BARYTA CARBONICA, BORAX, CALCAREA CARBONICA, CINCHONA OFFICINALIS, GLANDULA SUPRARENALIS SUIS, HYDROFLUORICUM ACIDUM, MERCURIUS SOLUBILIS, MEZEREUM, NATRUM MURIATICUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SEPIA, SILICEA, SULPHUR, THUJA OCCIDENTALIS, VINCA MINOR | The Wellness Center for Research and Education, Inc. | 8ecc05ff-ed5a-4157-9100-1c7912686f07 | 2025-06-06 | Warnings | 451W47IQ8X |
| MBM 7 Lung | COCCUS CACTI, LUNG (SUIS), IGNATIA AMARA, CAUSTICUM, NATRUM MURIATICUM | The Wellness Center for Research and Education, Inc. | 6eb49fb5-485c-4b48-b231-4db88ebe20df | 2025-06-04 | Warnings | 451W47IQ8X |
| PRISMASOL BGK2/0 | MAGNESIUM CHLORIDE, DEXTROSE ANHYDROUS, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE, AND POTASSIUM CHLORIDE | Vantive US Healthcare LLC | 7f675fee-8940-4ece-bb0c-75ac79d8708c | 2025-05-31 | Warnings, Adverse reactions | 451W47IQ8X |
| Sterile Water | WATER | Henry Schein, Inc. | 88403fcf-a276-42c0-88b6-bd84a720b564 | 2025-05-29 | Warnings, Adverse reactions | 059QF0KO0R |
| Resentment | ADRENALINUM, AMMONIUM MURIATICUM, APOCYNUM CANNABINUM, BUTHUS AUSTRALIS, CARDUUS MARIANUS, CINCHONA OFFICINALIS, FEL TAURI, HEPAR SUIS, HEPAR SULPHURIS CALCAREUM, HYPOTHALAMUS SUIS, MANGANUM CARBONICUM, MOSCHUS, NAJA TRIPUDIANS, NATRUM MURIATICUM, NITRICUM ACIDUM, NUX VOMICA, RHUS TOX, TARAXACUM OFFICINALE | Deseret Biologicals, Inc. | d397ed9c-10f0-4a99-baca-a31e5e18572a | 2025-05-27 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.